North America Acute Repetitive Seizures Market Size & Outlook

The acute repetitive seizures market in North America is expected to reach a projected revenue of US$ 2,712.2 million by 2030. A compound annual growth rate of 12.2% is expected of North America acute repetitive seizures market from 2025 to 2030.
Revenue, 2024 (US$M)
$1,357.7
Forecast, 2030 (US$M)
$2,712.2
CAGR, 2025 - 2030
12.2%
Report Coverage
North America

North America acute repetitive seizures market, 2018-2030 (US$M)

To keep accessing Horizon, please sign in or register for a free account

  • Access to global market statistics
  • Access to company profiles
  • Free use-cases & research insights

No credit card required*

North America acute repetitive seizures market, 2018-2030 (US$M)

North America acute repetitive seizures market highlights

  • The North America acute repetitive seizures market generated a revenue of USD 1,357.7 million in 2024.
  • The market is expected to grow at a CAGR of 12.2% from 2025 to 2030.
  • In terms of segment, usl-261 was the largest revenue generating drug class in 2024.
  • AZ-002 is the most lucrative drug class segment registering the fastest growth during the forecast period.
  • Country-wise, Mexico is expected to register the highest CAGR from 2025 to 2030.

North America data book summary

Market revenue in 2024USD 1,357.7 million
Market revenue in 2030USD 2,712.2 million
Growth rate12.2% (CAGR from 2025 to 2030)
Largest segmentUsl-261
Fastest growing segmentAZ-002
Historical data covered2018 - 2023
Base year for estimation2024
Forecast period covered2025 - 2030
Quantitative unitsRevenue in USD million
Market segmentationUSL-261, NRL-1, AZ-002, Diastat
Key market players worldwideUCB SA, Neurelis, Bausch Health Companies Inc, Alexza Pharmaceuticals, Veritone Inc

Other key industry trends

  • In terms of revenue, North America region accounted for 43.0% of the global acute repetitive seizures market in 2024.
  • Globally, North America is projected to lead the regional market in terms of revenue in 2030.
  • Asia Pacific is the fastest growing regional market and is projected to reach USD 1,464.9 million by 2030.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Acute Repetitive Seizures Market Companies

Name Profile # Employees HQ Website

North America acute repetitive seizures market outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to acute repetitive seizures market will help companies and investors design strategic landscapes.


Usl-261 was the largest segment with a revenue share of 44.53% in 2024. Horizon Databook has segmented the North America acute repetitive seizures market based on usl-261, nrl-1, az-002, diastat covering the revenue growth of each sub-segment from 2018 to 2030.


Reasons to subscribe to North America acute repetitive seizures market databook:

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of North America acute repetitive seizures market databook

  • Our clientele includes a mix of acute repetitive seizures market companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of continent-level data and insights on the North America acute repetitive seizures market, including forecasts for subscribers. This continent databook contains high-level insights into North America acute repetitive seizures market from 2018 to 2030, including revenue numbers, major trends, and company profiles.

Partial client list

  • logo

North America acute repetitive seizures market size, by country, 2018-2030 (US$M)

North America Acute Repetitive Seizures Market Share, 2024 & 2030 (US$M)

North America acute repetitive seizures market size, by country, 2018-2030 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more